SCHEMBL4392530

SCHEMBL4392530

OC[C@@]1(F)O[C@H](F)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ IDUA P35475 1/20 0.47
▸ FUCA1 P04066 1/20 0.32
▸ GBA1 P04062 1/20 0.30
▸ GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21067530 1.00 IDUA (0.47) IDUAFUCA1GBA1GAA
SCHEMBL21067531 1.00 IDUA (0.47) IDUAFUCA1GBA1GAA
SCHEMBL16629463 0.78 IDUA (0.31) IDUA
SCHEMBL263944 0.78 IDUA (0.31) IDUA
SCHEMBL15828336 0.78 IDUA (0.31) IDUA
SCHEMBL3982668 0.77 — —
SCHEMBL3982678 0.77 — —
SCHEMBL3975872 0.77 — —
SCHEMBL3975869 0.77 — —
SCHEMBL18016480 0.74 FUCA1 (0.32) FUCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090041740-A1 CANCER TREATMENT BY METABOLIC MODULATIONS ENGENE, INC. (CA) 2009-02-12 — — US disclosed
US-20050202559-A1 Cancer treatment by metabolic modulations HERCULES CAPITAL, INC. 2005-09-15 — — US disclosed
EP-1556088-A2 COMPOSITIONS FOR CANCER TREATMENT Engene, Inc. (CA) 2005-07-27 — — EP disclosed
WO-2004039412-A2 COMPOSITIONS FOR CANCER TREATMENT ENGENE, INC. (CA) 2004-05-13 — — WO disclosed
Send feedback